Ofatumumab Clinical Trials
8 recruitingBiologic
Phase 23Phase 31Phase 11
Showing 1–8 of 8 trials
Recruiting
Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Refractory Acute Lymphoblastic LeukemiaRecurrent Acute Lymphoblastic LeukemiaRecurrent Adult Lymphoblastic Lymphoma+8 more
M.D. Anderson Cancer Center42 enrolled1 locationNCT03136146
Recruiting
Phase 1Phase 2
Ofatumumab in AQP4-IgG Seropositive NMOSD
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital5 enrolled1 locationNCT05504694
Recruiting
Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels
Multiple Sclerosis
Third Affiliated Hospital, Sun Yat-Sen University80 enrolled1 locationNCT07353216
Recruiting
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals160 enrolled14 locationsNCT06486779
Recruiting
Phase 2
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma
M.D. Anderson Cancer Center80 enrolled1 locationNCT02877303
Recruiting
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
Multiple Sclerosis
Biogen1,178 enrolled1 locationNCT05688436
Recruiting
Phase 3
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
The First People's Hospital of Changzhou200 enrolled2 locationsNCT06867991
Recruiting
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals174 enrolled10 locationsNCT05809986